Results 11 to 20 of about 29,547 (250)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis [PDF]

Current Oncology, 2023
Background: Metastatic intrahepatic cholangiocarcinoma still has a dismal prognosis. The aim of our study was to investigate the prognostic role of bone metastases in patients affected by intrahepatic cholangiocarcinoma.
Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli   +6 more
doaj   +3 more sources

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma [PDF]

Current Oncology, 2022
Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration.
Falk Rauchfuß, Aladdin Ali-Deeb, Oliver Rohland, Felix Dondorf, Michael Ardelt, Utz Settmacher   +5 more
doaj   +2 more sources

Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma

Tumor Biology, 2017
The incidence rate of intrahepatic cholangiocarcinoma is rising, and treatment options are limited. Therefore, new biological markers of intrahepatic cholangiocarcinoma are needed.
Ze-Wu Meng, Min-Chao Liu, Hai-Jie Hong, Qiang Du, Yan-Ling Chen   +4 more
doaj   +2 more sources

Intrahepatic cholangiocarcinoma

Вестник рентгенологии и радиологии, 2016
The paper gives information on current approaches to diagnosing and treating intrahepatic cholangiocarcinoma (IHC), its microscopic and macroscopic varieties. It details the specificfeatures of images of IHC by ultrasonography, X-ray computed tomography,
A. B. Luk’yanchenko, B. M. Medvedeva, M. A. Shabanov, E. R. Virshke, V. V. Breder, K. A. Romanova   +5 more
doaj   +3 more sources

Current principles for the surgical treatment of intrahepatic cholangiocarcinoma

Journal of Mind and Medical Sciences
Intrahepatic cholangiocarcinoma is one of the most aggressive forms of cancer. It is usually diagnosed in advanced stages of the disease, mainly because it is asymptomatic for a long time after the onset.
Catalin Savin, Luiza Tarca, Irina Balescu, Sorin Petrea, Bogdan Gaspar, Lucian Pop, Valentin Varlas, Adrian Hasegan, Gabriel Petre Gorecki, Cristina Martac, Marilena Stoian, Cristian Balalau, Nicolae Bacalbasa   +12 more
doaj   +2 more sources

Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma

Annals of Hepatology, 2017
Purpose: To investigate the prevalence, related risk factors, and survival of intrahepatic cholangiocarcinoma in a Mexican population. Material and methods: We conducted a cross-sectional study at Medica Sur Hospital in Mexico City with approval of the ...
Paulina Chinchilla-López, Nancy E. Aguilar-Olivos, Jaime García-Gómez, Karen K. Hernández-Alejandro, Fredy Chablé-Montero, Daniel Motola-Kuba, Tushar Patel, Nahum Méndez-Sánchez   +7 more
doaj   +2 more sources

Intrahepatic Sarcomatous Cholangiocarcinoma: Case Report and Review of the Literature [PDF]

Case Reports in Surgery, 2018
The authors report a case of a patient with intrahepatic sarcomatous cholangiocarcinoma. A 45-year-old Thai man presented with a 3-month history of right upper abdominal pain.
Thana Boonsinsukh, Vichit Viriyaroj, Thammanij Rookkachart, Therdkiat Trongwongsa   +3 more
doaj   +2 more sources

Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma [PDF]

Canadian Journal of Gastroenterology, 2011
BACKGROUND: Currently, the most effective treatment for intrahepatic cholangiocarcinoma (ICC) is complete hepatic tumour excision.
Bei-ge Jiang, Rui-liang Ge, Liang-liang Sun, Ming Zong, Gong-tian Wei, Yong-jie Zhang   +5 more
doaj   +2 more sources

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation

Hepatology, EarlyView., 2022
Abstract Background and Aims Intrahepatic cholangiocarcinoma (ICC) is a deadly but poorly understood disease, and its treatment options are very limited. The aim of this study was to identify the molecular drivers of ICC and search for therapeutic targets.
Yuto Shiode, Takahiro Kodama, Satoshi Shigeno, Kazuhiro Murai, Satoshi Tanaka, Justin Y. Newberg, Jumpei Kondo, Shogo Kobayashi, Ryoko Yamada, Hayato Hikita, Ryotaro Sakamori, Hiroshi Suemizu, Tomohide Tatsumi, Hidetoshi Eguchi, Nancy A. Jenkins, Neal G. Copeland, Tetsuo Takehara   +16 more
wiley   +1 more source

Clinically unsuspected primary hepatic mucosa-associated lymphoid tissue lymphoma collision with an intrahepatic cholangiocarcinoma: A case report and literature review

SAGE Open Medical Case Reports, 2021
A synchronous tumor represents two histologically distinct neoplasms occurring at the same anatomic site, each displaying a distinct tumorigenesis pathway; they can be primary, secondary, or a mixture. The occurrence of an adenocarcinoma and lymphoma has
Stefanie Grewe, Mohammad Shahid, Ling Zhang, Kun Jiang   +3 more
doaj   +1 more source